2002
back to LION bioscience home
SitemapPrintable version of this documentContact LIONZur deutschen Version dieses Dokuments LION bioscience AG
Press
Press Releases
2004
2003
2002
2001
2000
1999
1998
1997
Ad-Hoc Releases
Online Press Kit
Events
Photos & Logos
Glossary
PR Contact
 

© 2004 LION bioscience AG
Disclaimer
Imprint/Contact
Contact Webmaster
2002
 
 
 December 2002
2002/12/19
LION bioscience Licenses SRS Evolution to Italian Biomedical Research Company Siena Biotech
· LION Expands Presence in Italy’s Life Science Market

2002/12/18
LION bioscience to Receive Milestone Payment from Bayer for Integrated Cheminformatics Project
· Bayer to Pay 2 Million Dollars for Delivery of Software Components
· Bayer to Use LION DiscoveryCenter™ for Parts of the Project
· New Agreement Gives LION Larger Share of Project Responsibilities

 
 November 2002
2002/11/06
LION bioscience Reports Second-Quarter Results for Fiscal Year 2002/2003
· Cost Reduction Program and New Integration Solutions On Track

 
 October 2002
2002/10/29
LION bioscience & IBM to Offer On-Demand Computing for Drug Research
· IBM to Sell and Co-Market LION Hosted Services™ for More Cost-Efficient Access to Life Science Informatics

2002/10/21
LION bioscience Revises Outlook for FY 2003
· Lower Revenue and Non-cash Write-Offs Result in Increased Loss

2002/10/01
LION bioscience and PerkinElmer Release SNPscorer for Better Genotype Analysis
· Scoring Functionality Helps Researchers Analyze Data Quality and Accuracy

 
 September 2002
2002/09/24
LION bioscience AG Chooses GemStone Systems and JBoss to Run iDEA™
· A tool to support drug discovery acceleration and research cost reduction through early identification of successful drug candidates

2002/09/19
LION bioscience Licenses SRS & bioSCOUT to French Crop Science Firms for Better Research Management
· Deals Mark LION's Entry into Large French Crop Science Market

2002/09/06
LION bioscience Discontinues Drug Discovery Business as Planned to Focus on Core IT Expertise
· Strategic Move to Reduce Costs, Bolster Cash Position

 
 August 2002
2002/08/07
LION bioscience Reports First Quarter Fiscal Year 2002/2003 Results
· LION On-Track with its Transition to Solutions-based Model and New
· Processes and Cost Management

2002/08/06
Analyst Report on LION bioscience Project with Bayer Cites Benefits of Outsourcing Bioinformatics

2002/08/05
LION bioscience Presents LION DiscoveryCenter™ to Help Speed Drug Discovery
· Comprehensive Integration Platform Aimed at Industry Need for Linking Biology and Chemistry Data

2002/08/01
LION bioscience AG Expands Market Share in India with Exclusive Distributor Jubilant Organosys
· Lion Gains Foothold in India with First Customer

2002/08/01
LION bioscience AG Expands Asian Market Penetration to Taiwan
· LION Signs Reseller Agreement with DigiGenomics

 
 July 2002
2002/07/19
LION bioscience AG: More Than 600 Shareholders Attend Annual General Meeting
· Jürgen Dormann Elected New Supervisory Board Chairman
· Annual General Shareholders’ Meeting Welcomes Focus on Life Science Informatics

2002/07/19
Jürgen Dormann Elected Chairman of LION bioscience’s Supervisory Board

2002/07/08
Market Analysis Supports LION’s Focus on IT Solutions as the Primary Value Driver for Drug Discovery
· R&D Informatics Could Add $165 Million in Value to Each Drug Through Time and Cost Savings

2002/07/01
LION bioscience AG Rapidly Grows Market Share in Japan with Exclusive Distributor CTCLS
· Leading Japanese Life Science Companies License LION’s Products

 
 June 2002
2002/06/27
LION bioscience Announces Release of SRS Evolution
· Big Pharma Completes Successful Testing of LION’s SRS Relational System

2002/06/27
LION bioscience Names Dr. Daniel Keesman to Chief Business Officer
· New LION Board Position to Better Serve Customer Needs

2002/06/25
LION bioscience AG Licenses iDEA™ Software to Pfizer
· A tool to support drug discovery acceleration and research cost reduction through early identification of successful drug candidates

2002/06/20
LION bioscience Helps Cleveland Clinic Foundation Improve Research with Data Integration Power
· Leading U.S. research hospital chooses LION's integration platform to improve research performance and productivity

2002/06/11
Paradigm Genetics, LION bioscience Win $11.7 Million ATP Grant
· Federal Money to Fund Bioinformatics System for Therapeutic Target Assessment

2002/06/05
LION bioscience Reports Significant Revenue Growth of 73% in Fiscal Year 2001/2002 Despite Difficult Market Conditions
· Basis Established to Expand Leading Market Position in Integration Solutions
· LION Confirms Goal to Break-Even in Q4 of Fiscal Year 2003/2004

 
 April 2002
2002/04/02
LION bioscience Provides Incyte with SRS Integration Power for Better Genomics Analysis and Faster Drug Discovery
· LION’s Position as Industry Standard for Data Integration Further Strengthened

 
 March 2002
2002/03/18
Martin Hollenhorst to Become New CFO of LION bioscience AG

2002/03/14
LION bioscience AG and GeneProt Team Up for Better Proteomics Integration
· Combination of Leading Integration Platform and Industrial Scale Proteomics Capabilities Delivers Increased Offerings to Life Sciences Companies

 
 February 2002
2002/02/15
LION bioscience AG strengthens the prerequisite for strong revenue growth

2002/02/07
LION bioscience Announces Sale of its Shareholdings in Tripos Inc.
· No Strategic need for Tripos shareholding after Successful Completion of NetGenics acquisition

2002/02/06
LION and Nestlé broaden collaboration
· Implementation of knowledge management system for IT driven research process

2002/02/06
LION bioscience AG: Stable Growth and Reduced Losses in the Third Quarter of Fiscal Year 2002

 
 January 2002
2002/01/31
LION bioscience Announces Completion of the Acquisition of NetGenics Inc.

2002/01/22
Derwent to offer premier information source on genetic sequences filed in patents based on LION’s SRS technology

2002/01/15
LION bioscience AG to Acquire NetGenics Inc.
· The race for the multidisciplinary integration platform is finished